Drugs / Monovalent Subvirion A/H1N1 Influenza vaccine
Monovalent Subvirion A/H1N1 Influenza vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00952419 | Aug 2009 → Mar 2010 | swine influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Monovalent Subvirion A/H1N1 Influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00952419 ↗ |
| Modality | Vaccine | “pandemic (H1N1) 2009 vaccine” PMID 21219979 ↗ Jan 2011 |
| Route | Intramuscular | “0.5 mL, Intramuscular Day 0 and Day 21 (3 to 9 years); 0.25 mL, Intramuscular on Day 0 and Day 21 (6 months to 35 Months)” NCT00952419 ↗ |